Tao Cheng

Tao Cheng

Auto-generated profile, based on publicly available information

Tao Cheng

Institute of Hematology and Blood Diseases Hospital

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
XXXuemei Xie
Xuemei Xie
QSQiang Shi
Qiang Shi
PWPeng Wu
Peng Wu
XZXiaoyu Zhang
Xiaoyu Zhang
HKHiroto Kambara
Hiroto Kambara
HLHongbo R. Luo
Hongbo R. Luo

1 April 2021 in Cell
Verified
Journal Article
Closed access
XRXianwen Ren
Xianwen Ren
WWWen Wen
Wen Wen
XFXiaoying Fan
Xiaoying Fan
WHWenhong Hou
Wenhong Hou
BSBin Su
Bin Su
ZZZemin Zhang
Zemin Zhang

20 February 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
JZJian-Ping Zhang
Jian-Ping Zhang
XLXiao-Lan Li
Xiao-Lan Li
GLGuo-Hua Li
Guo-Hua Li
WCWanqiu Chen
Wanqiu Chen
CACameron Arakaki
Cameron Arakaki
XZXiao-Bing Zhang
Xiao-Bing Zhang
Background: Precise genome editing via homology-directed repair (HDR) after double-stranded DNA (dsDNA) cleavage facilitates functional genomic research and holds promise for gene therapy. However, HDR efficiency remains low in some cell types, including some of great research and clinical interest, such as human induced pluripotent stem cells (iPSCs). Results: Here, we show that a double cut HDR donor, which is flanked by single guide RNA (sgRNA)-PAM sequences and is released after CRISPR/Cas9 cleavage, increases HDR efficiency by twofold to fivefold relative to circular plasmid donors at one genomic locus in 293 T cells and two distinct genomic loci in iPSCs. We find that a 600 bp homology in both arms leads to high-level genome knockin, with 97–100% of the donor insertion events being mediated by HDR. The combined use of CCND1, a cyclin that functions in G1/S transition, and nocodazole, a G2/M phase synchronizer, doubles HDR efficiency to up to 30% in iPSCs. Conclusions: Taken together, these findings provide guidance for the design of HDR donor vectors and the selection of HDR-enhancing factors for applications in genome research and precision medicine.

12 January 2024 in Science
Verified
Journal Article
Closed access
MNMelissa S. F. Ng
Melissa S. F. Ng
IKImmanuel Kwok
Immanuel Kwok
LTLeonard Tan
Leonard Tan
CSChangming Shi
Changming Shi
DCDaniela Cerezo-Wallis
Daniela Cerezo-Wallis
LNLai Guan Ng
Lai Guan Ng
Neutrophils are increasingly recognized as key players in the tumor immune response and are associated with poor clinical outcomes. Despite recent advances characterizing the diversity of neutrophil states in cancer, common trajectories and mechanisms governing the ontogeny and relationship between these neutrophil states remain undefined. Here, we demonstrate that immature and mature neutrophils that enter tumors undergo irreversible epigenetic, transcriptional, and proteomic modifications to converge into a distinct, terminally differentiated dcTRAIL-R1 + state. Reprogrammed dcTRAIL-R1 + neutrophils predominantly localize to a glycolytic and hypoxic niche at the tumor core and exert pro-angiogenic function that favors tumor growth. We found similar trajectories in neutrophils across multiple tumor types and in humans, suggesting that targeting this program may provide a means of enhancing certain cancer immunotherapies.

14 June 2019 in Protein & Cell
Verified
Journal Article
Open access
PDF file
HCHui Cheng
Hui Cheng
ZZZhaofeng Zheng
Zhaofeng Zheng
TCTao Cheng
Tao Cheng
Ever since hematopoietic stem cells (HSCs) were first identified half a century ago, their differentiation roadmap has been extensively studied. The classical model of hematopoiesis has long held as a dogma that HSCs reside at the top of a hierarchy in which HSCs possess self-renewal capacity and can progressively give rise to all blood lineage cells. However, over the past several years, with advances in single cell technologies, this developmental scheme has been challenged. In this review, we discuss the evidence supporting heterogeneity within HSC and progenitor populations as well as the hierarchical models revised by novel approaches mainly in mouse system. These evolving views provide further understanding of hematopoiesis and highlight the complexity of hematopoietic differentiation.

9 February 2014 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
XZXiaofan Zhu
Xiaofan Zhu
FHFuhong He
Fuhong He
HZHuimin Zeng
Huimin Zeng
SLShaoping Ling
Shaoping Ling
ACAili Chen
Aili Chen
QWQian-Fei Wang
Qian-Fei Wang